ISRG241220P552500
- 12.45
- 0.000.00%
Intuitive Surgical Newsroom
RBC Capital Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $611
Intuitive Surgical Analyst Ratings
Truist Financial Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Announces Target Price $640
RBC Capital Adjusts Intuitive Surgical Price Target to $611 From $555, Maintains Outperform Rating
Baird Adjusts Intuitive Surgical Price Target to $630 From $565, Maintains Outperform Rating
Mizuho Securities Maintains Intuitive Surgical(ISRG.US) With Hold Rating, Raises Target Price to $570
Bernstein Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $650
Citigroup Maintains Buy on Intuitive Surgical, Raises Price Target to $640
Intuitive Surgical Analyst Ratings
Wells Fargo Maintains Overweight on Intuitive Surgical, Raises Price Target to $630
Citi Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $640
Wells Fargo Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $630
Stifel Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $610
Intuitive Surgical Analyst Ratings
Stifel Adjusts Price Target on Intuitive Surgical to $610 From $525, Keeps Buy Rating
Morgan Stanley Initiates Intuitive Surgical(ISRG.US) With Buy Rating, Announces Target Price $650
Intuitive Surgical (ISRG) Gets a Buy From Leerink Partners
Intuitive Surgical Is Maintained at Buy by BTIG
Intuitive Surgical Analyst Ratings
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $561